Global Patient Clinical Data Registry Software Market Size study & Forecast, by Registry (Disease Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-alone Software and Integrated Software), by End User (Hospitals,

Global Patient Clinical Data Registry Software Market Size study & Forecast, by Registry (Disease Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-alone Software and Integrated Software), by End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other End Users), and Regional Analysis, 2023-2030

Global Patient Clinical Data Registry Software Market is valued approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030.
Patient Clinical Data Registry Software are the platforms meticulously crafted to gather, organize, and analyze patient-centric data sourced from diverse healthcare environments. These sophisticated systems serve as crucial drivers in elevating healthcare outcomes by fostering the consolidation of extensive patient data, empowering healthcare practitioners and researchers to extract valuable insights. The increasing prevalence of chronic illnesses, combined with the escalating focus on evidence-driven healthcare, has spurred the widespread adoption of Patient Clinical Data Registry Software on a global scale. These platforms not only streamline the process of data collection and administration but also bolster decision-making capabilities, quality enhancement endeavors, and the advancement of clinical research initiatives. The market growth is driven by key factors such as increasing Emphasis on Value-Based Care, technological Advancements and Integration of AI/ML.

Artificial intelligence (AI) and, specifically, machine learning (ML) represent groundbreaking technologies that are reshaping and impacting the patient clinical data registry software market. By automating tasks such as data analysis, identifying patterns, and enabling predictive analytics, these technologies enhance the functionality of data registry platforms. As per Statista, In 2021, 42 percent of healthcare organizations within the European Union were already leveraging AI technologies for disease diagnosis, with an additional 19 percent intending to integrate this technology within the next three years. Moreover, 33 percent of the surveyed healthcare organizations had intentions to adopt AI-based patient monitoring tools within the same timeframe. Also, The global market size for artificial intelligence in healthcare reached USD 1.098 billion in 2016. Projections indicate a significant surge in this market, with estimates suggesting it will surpass USD 28 billion by the year 2025, marking substantial growth from its initial one-billion-dollar valuation. However, data Security Concerns and Privacy Issues, and Interoperability Challenges stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Patient Clinical Data Registry Software Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominates the market, driven by its widespread adoption of advanced healthcare technologies, robust regulatory frameworks, and commitment to value-based care. The region benefits from a well-established healthcare system that encourages the utilization of Patient Clinical Data Registry Software, facilitating improved patient outcomes, streamlined data processing, and evidence-based decision-making. On the other hand, the Asia-Pacific region is witnessing the fastes growth, propelled by its rapid development of healthcare infrastructure. This progress enables the implementation of advanced data registry solutions even in developing economies within the region.

Major market player included in this report are:
Global Vision Technologies Inc.
Dacima Software Inc.
FIGmd Inc.
Image Trend Inc.
IQVIA
Ordinal Data, Inc.
McKensson Corporation
Syneos Health
Velos Inc.
Cerner Corporation

Recent Developments in the Market:
 In November 2023, Alira Health, a globally recognized advisory and clinical research firm, joined forces with FORWARD, the National Databank for Rheumatic Diseases, and the largest patient-reported research databank for rheumatic disorders in the United States. Together, they have launched an enhanced Lupus Registry, aiming to offer enriched insights for patients, caregivers, and research sponsors. The initiative's primary goal is to advance patient outcomes through comprehensive data analysis and collaboration.
 In February 2022, EVERSANA and THREAD unveiled a groundbreaking joint solution tailored for pharmaceutical companies. This innovative offering merges EVERSANA's comprehensive commercial services, robust electronic medical record (EMR) data, and real-world data (RWD) recruitment capabilities with THREAD's cutting-edge decentralized clinical trial platform. By integrating patient-generated and secondary regulatory-grade RWD, the solution facilitates seamless data aggregation and linkage, empowering pharmaceutical companies to conduct more efficient and insightful clinical trials.
 In June 2022, Verana Health, a pioneering digital health firm committed to enhancing real-world data (RWD) quality, introduced VeraSite. This new subscription-based tool is meticulously designed to identify potential clinical trial sites with precision. VeraSite offers clinical trial sponsors and contract research organizations (CROs) a secure and streamlined approach to pinpointing practices with the requisite clinical expertise and suitable patient populations aligned with specific study protocols.

Global Patient Clinical Data Registry Software Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Registry Type, Type of Software, End-users, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study. The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Registry Type:
Disease Registries
Health Service Registries
Product Registries

By Types of Software:
Stand-alone Software
Integrated Software

By End-users:
Hospitals
Government Organizations
Third Party Administrators (TPAs)
Pharmaceutical, Biotechnology, and Medical Device Companies
Other End Users
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.